Rubicon Organics Establishes Route to Market for Cannabis 2.0 Products

Published: October 27, 2020

Rubicon Organics Establishes Route to Market for Cannabis 2.0 Products

Rubicon Organics Inc., a licensed producer, has signed a cannabis 2.0 product distribution agreement with Canada House Wellness Group Inc. through Canada House’s wholly-owned subsidiary of Abba Medix Corp. In connection with the Agreement, Canada House will distribute Rubicon Organics’ line of concentrate products to Canada House’s provincial distributors while the Company waits to receive from Health Canada its authorization for sale of extracts, topicals and edibles.

“With our route to market established for cannabis 2.0 products, we are excited to begin executing on our innovation pipeline. In the coming months, we will be launching our new premium concentrate brand along with a diverse portfolio of products. These products will highlight the terpene rich profile that our organic and sustainably cultivated Simply BareTM flower has become known for,” said Jesse McConnell, Chief Executive Officer. “We are delighted to be partnering with Canada House to accelerate our time to market whilst we wait for Health Canada to issue our extract, edible and topical sales license that we submitted for in early September.”

Rubicon Organics Inc. is becoming the global brand leader in organic cannabis products. Through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer, the Company cultivates and sells organic certified, sustainably grown, super-premium cannabis from its state-of-the-art hybrid greenhouse located in Delta, BC, Canada.

Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.

Canada House Wellness Group’s goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally. Please visit or the Company’s public filings at